Anika Therapeutics Ownership | Who Owns Anika Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Anika Therapeutics Ownership Summary


Anika Therapeutics is owned by 84.79% institutional investors, 3.42% insiders, and 11.79% retail investors. Trigran investments is the largest institutional shareholder, holding 13.69% of ANIK shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.10% of its assets in Anika Therapeutics shares.

ANIK Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAnika Therapeutics84.79%3.42%11.79%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryMedical Device Stocks40.18%9.93%49.89%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Trigran investments2.02M13.69%$33.28M
Blackrock1.61M10.93%$40.70M
Blackrock funding, inc. /de1.56M10.55%$25.64M
Caligan partners lp1.44M9.72%$23.62M
Vanguard group765.27K5.18%$12.60M
Alta fundamental advisers700.43K4.74%$11.53M
Dimensional fund advisors lp657.36K4.45%$10.82M
Boothbay fund management529.50K3.59%$8.72M
Renaissance528.52K3.58%$8.70M
Morgan stanley501.99K3.42%$12.72M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Caligan partners lp1.44M5.98%$23.62M
Trigran investments2.02M3.83%$33.28M
Alta fundamental advisers700.43K3.45%$11.53M
Stonepine capital management238.22K3.17%$3.92M
Meros investment management, lp177.68K1.31%$2.92M
Capital management corp /va325.55K0.96%$5.36M
Diker management56.84K0.81%$935.57K
Boothbay fund management529.50K0.21%$8.72M
Ironwood investment management25.66K0.21%$422.43K
Virtus fund advisers2.72K0.14%$44.84K

Top Buyers

HolderShares% AssetsChange
Alta fundamental advisers700.43K3.45%404.35K
Jpmorgan chase82.49K0.00%66.98K
Ubs group68.72K0.00%61.18K
Stonepine capital management238.22K3.17%48.91K
Blackrock1.61M0.00%45.79K

Top Sellers

HolderShares% AssetsChange
Blackrock funding, inc. /de1.56M0.00%-206.72K
Morgan stanley501.99K0.00%-199.74K
Franklin resources---133.41K
Segall bryant & hamill---108.80K
Trigran investments2.02M3.83%-102.68K

New Positions

HolderShares% AssetsChangeValue
Xtx topco21.37K0.03%21.37K$351.70K
Exoduspoint capital management, lp16.04K0.00%16.04K$264.00K
Mackenzie financial14.05K0.00%14.05K$101.63K
Aquatic capital management2.58K0.00%2.58K$42.43K
Ronald blue trust56.00-56.00$1.38K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-3.00
Assetmark-3.00
Covestor-24.00
Parallel advisors-39.00
Bessemer group-50.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024110-10.57%12,521,428-4.37%841.08%538.16%39-18.75%
Sep 30, 20241236.96%13,093,709-1.09%881.11%49-2.00%48-
Jun 30, 2024113-6.61%13,237,819-1.18%901.08%49-14.04%4714.63%
Mar 31, 20241213.42%13,396,4641.35%911.12%57-6.56%412.50%
Dec 31, 2023117-0.85%13,218,4421.65%901.14%617.02%40-11.11%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF439.41K3.10%-
Vanguard Total Stock Mkt Idx Inv439.41K3.05%-
iShares Russell 2000 ETF317.19K2.24%-2.75K
Vanguard Institutional Extnd Mkt Idx Tr223.41K1.55%735.00
CMC SMID226.91K1.55%30.39K
Fidelity Small Cap Index127.55K0.90%-2.39K
Franklin Mutual Small-Mid Cap Val A120.97K0.83%-
DFA US Targeted Value I112.34K0.79%-
DFA US Micro Cap I95.06K0.67%-5.72K
State St Russell Sm/Mid Cp® Indx NL Cl C93.16K0.65%-

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1--

ANIK Ownership FAQ


Who Owns Anika Therapeutics?

Anika Therapeutics shareholders are primarily institutional investors at 84.79%, followed by 3.42% insiders and 11.79% retail investors. The average institutional ownership in Anika Therapeutics's industry, Medical Device Stocks, is 40.18%, which Anika Therapeutics exceeds.

Who owns the most shares of Anika Therapeutics?

Anika Therapeutics’s largest shareholders are Trigran investments (2.02M shares, 13.69%), Blackrock (1.61M shares, 10.93%), and Blackrock funding, inc. /de (1.56M shares, 10.55%). Together, they hold 35.17% of Anika Therapeutics’s total shares outstanding.

Does Blackrock own Anika Therapeutics?

Yes, BlackRock owns 10.93% of Anika Therapeutics, totaling 1.61M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 40.7M$. In the last quarter, BlackRock increased its holdings by 45.79K shares, a 2.93% change.

Who is Anika Therapeutics’s biggest shareholder by percentage of total assets invested?

Caligan partners lp is Anika Therapeutics’s biggest shareholder by percentage of total assets invested, with 5.98% of its assets in 1.44M Anika Therapeutics shares, valued at 23.62M$.

Who is the top mutual fund holder of Anika Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Anika Therapeutics shares, with 3.10% of its total shares outstanding invested in 439.41K Anika Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools